All wegovy Articles

How a boom in weight loss drugs could fatten construction firms’ order backlogs
A new generation of diabetes and weight-loss drugs are sparking a boom in pharmaceutical factory construction projects
Novo Nordisk to spend $1.1bn to expand Brazilian plant
Danish drug company Novo Nordisk has announced plans to invest 6.4 billion reais (US$1.1 billion) to expand production at a manufacturing plant in Brazil.
Drug-maker Novo Nordisk to spend $4.1bn on construction of US Wegovy facility
Premium Content
Danish drug-maker Novo Nordisk is to spend $4.1 billion to build a new US facility to fill injection pens for its popular weight-loss treatment Wegovy